Metyrapone
ATC V04CD01 · 5 markets · 10 records
GB 3 records · 1 strengths
- 250 mgcapsuleMetopironeManufacturer: A A H Pharmaceuticals Ltd、Manufacturer: Esteve Pharmaceuticals Ltd
US 2 records · 1 strengths
- 250 mgcapsuleMetopirone
AU 2 records · 2 strengths
- 250 mgcapsuleMETOPIRONE 250 metyrapone 250mg capsule bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 250 mgcapsuleMETYRAPONE ESTEVE 250 mg, capsule molle
| Strength / form / release | US | GB | AU | HK | FR |
|---|---|---|---|---|---|
| 250 mg capsule | Metopirone | Manufacturer: A A H Pharmaceuticals Ltd Manufacturer: Esteve Pharmaceuticals Ltd Metopirone | METOPIRONE 250 metyrapone 250mg capsule bottle | METYRAPONE ESTEVE 250 mg, capsule molle | |
unknown | Metopirone | Metopirone |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.